Top Stories

Biogen, Eli Lilly and AMC


The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.

John Tlumacki | Boston Globe | Getty Images

Check out the companies making headlines in midday trading.

Biogen Shares of Biogen shot up 38.3% after the FDA approved the company’s Alzheimer’s drug, the first new medicine for the disease in nearly two decades. Trading of Biogen was halted earlier on Friday when the Food and Drug Administration announced the news, and was paused again in the afternoon for volatility.

Eli Lilly and Company The biopharmaceutical stock jumped 10% after the approval of Biogen’s Alzheimer’s medicine by the FDA. Eli Lilly is developing its own drug


0 0 votes
Article Rating

The Fed is in early stages of prepping markets for tapering asset purchases

Previous article

Five Below CEO says retailer is well positioned to handle inflation

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Top Stories